Trading update

RNS Number : 4295O
EKF Diagnostics Holdings PLC
07 November 2016
 

 

EKF Diagnostics Holdings plc

("EKF", the "Company")

 

Trading update

 

EKF Diagnostics Holdings plc (AIM: EKF), the AIM listed point-of-care business, announces that early trading in Q4 of the current financial year has again been materially higher than budget and at a run-rate in excess of already revised market forecasts, upgraded following the trading update provided on 7 October 2016.

 

The Company now believes that it will achieve revenues of at least £36.5m and adjusted EBITDA for the year ending 31 December 2016 of at least £5.5m, therefore exceeding current market forecasts. The strong performance of the business is due to organic growth.

 

In addition, the Company announces that cash generation continues to be strong and now expects to be close to breakeven if not cash positive by the year end, and then cash positive in the first quarter, again ahead of the board's previous expectations.

 

The announcement contains inside information for the purposes of Article 7 of Regulation (EU) No 596/2014.

 

 

 

EKF Diagnostics Holdings plc 

www.ekfdiagnostics.com

Christopher Mills, Non-Executive Chairman

Tel: 029 2071 0570

Julian Baines, CEO 


Richard Evans, FD & COO




Panmure Gordon (UK) Limited (NOMAD & Joint Broker)

Tel: 020 7886 2500

Freddy Crossley / Peter Steel (Corporate Finance)




N+1 Singer (Joint Broker)

Tel: 020 7496 3000

Alex Price / Alex Laughton-Scott




Walbrook PR Limited

Tel: 020 7933 8780 or ekf@walbrookpr.com  

Paul McManus / Lianne Cawthorne

Mob: 07980 541 893 / 07584 391 303

 


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTLLFIDLALSIIR
UK 100

Latest directors dealings